Page last updated: 2024-11-06

triethylenemelamine and Anemia

triethylenemelamine has been researched along with Anemia in 5 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TAYLOR, L1
MOLANDER, DW1
LADUE, JS1
BRIDGES, JB1
BRIDGES, JM1
EDELSTYN, GJ1
LYONS, AR1
BRODY, JI1
BEIZER, LH1
Silver, RT1

Reviews

1 review available for triethylenemelamine and Anemia

ArticleYear
The treatment of chronic lymphocytic leukemia.
    Seminars in hematology, 1969, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Ag

1969

Other Studies

4 other studies available for triethylenemelamine and Anemia

ArticleYear
IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA. RESPONSE OF A PATIENT TO REPEATED COURSES OF ALKYLATING AGENTS.
    The American journal of medicine, 1963, Volume: 35

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune

1963
CHRONIC LEUKEMIA.
    Geriatrics, 1964, Volume: 19

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alkylating Agents; Anemia; Anemia, Hemolytic,

1964
FEOTAL LIVER SUSPENSIONS IN THE TREATMENT OF MARROW APLASIA.
    British journal of cancer, 1965, Volume: 19

    Topics: Anemia; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Fetus; Hemoglobi

1965
ALTERATION OF BLOOD GROUP ANTIGENS IN LEUKEMIC LYMPHOCYTES.
    The Journal of clinical investigation, 1965, Volume: 44

    Topics: ABO Blood-Group System; Anemia; Anemia, Aplastic; Antigens; Blood Group Antigens; Child; Chlorambuci

1965